Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC Gray Market Peptides: So Much Hype, So Little Data In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few As unregulated peptides grow in popularity, doctors warn of unknown risks ABC30 Fresno